Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The synthesis of Active Pharmaceutical Ingredients (APIs) is a cornerstone of modern medicine, and the quality of the starting materials directly influences the success of the entire process. NINGBO INNO PHARMCHEM CO.,LTD., as a prominent manufacturer and supplier of pharmaceutical intermediates in China, recognizes the critical nature of compounds like Boc-(R)-3-Amino-4-(4-cyanophenyl)-butyric Acid. This specialized chemical serves as an indispensable building block, contributing significantly to the development and production of various therapeutic agents.
Boc-(R)-3-Amino-4-(4-cyanophenyl)-butyric Acid is characterized by its specific chirality and the presence of a nitrile group attached to a phenyl ring, alongside the amine functionality protected by a BOC group. This unique molecular architecture makes it highly sought after in asymmetric synthesis, a field vital for producing enantiomerically pure APIs. Pharmaceutical companies seeking to buy this intermediate often require precise specifications to ensure optimal reactivity and minimal by-product formation. Our facility is equipped to produce this compound with a high purity level of 97%, guaranteeing its suitability for demanding API manufacturing workflows.
As a manufacturer with a strong foothold in the global pharmaceutical supply chain, NINGBO INNO PHARMCHEM CO.,LTD. understands the importance of reliability and cost-efficiency. We offer Boc-(R)-3-Amino-4-(4-cyanophenyl)-butyric Acid at competitive prices, making it accessible for both research-scale projects and large-scale manufacturing. Our commitment extends beyond just supply; we aim to be a strategic partner for our clients. This includes ensuring a stable supply chain, providing timely delivery, and offering responsive customer support. When you need to procure this vital pharmaceutical raw material, choosing a dependable supplier like us is paramount for uninterrupted production.
The application of Boc-(R)-3-Amino-4-(4-cyanophenyl)-butyric Acid is diverse, ranging from the synthesis of enzyme inhibitors to novel peptide mimetics and other complex pharmaceutical entities. Its versatile nature allows chemists to explore various synthetic routes, leading to potential breakthroughs in drug discovery. For those looking to buy this intermediate, understanding its properties and sourcing it from a reputable manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is a strategic advantage. We leverage our expertise in chemical synthesis to consistently deliver products that meet the highest industry standards, supporting your journey from laboratory to market.
In summary, Boc-(R)-3-Amino-4-(4-cyanophenyl)-butyric Acid is a cornerstone intermediate for many advanced pharmaceutical syntheses. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a leading supplier in China, providing this essential compound with exceptional purity and competitive pricing. We are dedicated to supporting the pharmaceutical industry's quest for new and improved therapies by ensuring the quality and availability of critical chemical building blocks.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
